231 related articles for article (PubMed ID: 37105517)
1. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW;
J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517
[TBL] [Abstract][Full Text] [Related]
2. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.
Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW
CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199
[TBL] [Abstract][Full Text] [Related]
3. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.
Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052
[TBL] [Abstract][Full Text] [Related]
4. Skin Cancer and Hydrochlorothiazide: Novel Population-Based Analyses Considering Personal Risk Factors Including Race/Ethnicity.
Birck MG; Moura CS; Machado MAA; Liu JL; Abrahamowicz M; Pilote L; Bernatsky S
Hypertension; 2023 Oct; 80(10):2218-2225. PubMed ID: 37489540
[TBL] [Abstract][Full Text] [Related]
5. Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study.
Lin SY; Huang HY; Chiang LT; Huang LY; Wang CC
Hypertens Res; 2023 Oct; 46(10):2272-2279. PubMed ID: 37253976
[TBL] [Abstract][Full Text] [Related]
6. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
Park E; Lee Y; Jue MS
Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
[TBL] [Abstract][Full Text] [Related]
7. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
8. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
9. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
Suchard MA; Schuemie MJ; Krumholz HM; You SC; Chen R; Pratt N; Reich CG; Duke J; Madigan D; Hripcsak G; Ryan PB
Lancet; 2019 Nov; 394(10211):1816-1826. PubMed ID: 31668726
[TBL] [Abstract][Full Text] [Related]
11. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
[TBL] [Abstract][Full Text] [Related]
12. Half a century of hydrochlorothiazide: facts, fads, fiction, and follies.
Messerli FH; Bangalore S
Am J Med; 2011 Oct; 124(10):896-9. PubMed ID: 21962309
[TBL] [Abstract][Full Text] [Related]
13. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Acute Pancreatitis: A Population-Based Cohort Study.
Rouette J; Yin H; McDonald EG; Barkun A; Azoulay L
Drug Saf; 2022 Jan; 45(1):65-74. PubMed ID: 34714528
[TBL] [Abstract][Full Text] [Related]
14. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.
Tang H; Fu S; Zhai S; Song Y; Asgari MM; Han J
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):279-288. PubMed ID: 29318704
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
Agrawal R; Marx A; Haller H
J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
[TBL] [Abstract][Full Text] [Related]
16. Importance of accounting for timing of time-varying exposures in association studies: Hydrochlorothiazide and non-melanoma skin cancer.
Danieli C; Moura CS; Pilote L; Bernatsky S; Abrahamowicz M
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1411-1420. PubMed ID: 37528702
[TBL] [Abstract][Full Text] [Related]
17. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
18. Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational Studies.
Tang H; Fu S; Zhai S; Song Y; Han J
Drug Saf; 2018 Feb; 41(2):161-169. PubMed ID: 28905299
[TBL] [Abstract][Full Text] [Related]
19. Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population?
Carney K; Cousins M
Evid Based Dent; 2022 Mar; 23(1):38-39. PubMed ID: 35338330
[TBL] [Abstract][Full Text] [Related]
20. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
Vila-Corcoles A; Satue-Gracia E; Ochoa-Gondar O; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Rovira-Veciana D; Basora-Gallisa J
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1379-1388. PubMed ID: 32710674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]